Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/20/2026 | PUT | $22.00 | 242 | +36 | +17.48% |
| 02/20/2026 | CALL | $28.00 | 46 | +1 | +2.22% |
| 02/20/2026 | CALL | $3.00 | 0 | 0 | |
| 02/20/2026 | CALL | $5.00 | 0 | 0 | |
| 02/20/2026 | CALL | $7.00 | 0 | 0 | |
| 02/20/2026 | CALL | $8.00 | 0 | 0 | |
| 08/21/2026 | PUT | $37.00 | 0 | 0 | |
| 08/21/2026 | PUT | $40.00 | 0 | 0 | |
| 02/20/2026 | CALL | $20.00 | 501 | -1 | -0.20% |
| 02/20/2026 | CALL | $24.00 | 15 | -1 | -6.25% |
| 02/20/2026 | CALL | $30.00 | 107 | -1 | -0.93% |
| 04/17/2026 | CALL | $35.00 | 81 | -3 | -3.57% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Fidelity Advisor Biotechnology Fund | 2.31% | 1.46M | 10.27M |
| Fidelity Small Cap Growth Fund | 2.18% | 1.38M | 9.69M |
| Fidelity Series Small Cap Opportunities Fund | 2.01% | 1.27M | 8.95M |
| Vanguard Total Stock Market Index Fund | 1.88% | 1.19M | 8.37M |
| Fidelity Select Portfolios - Biotechnology | 1.86% | 1.18M | 8.29M |
| iShares Russell 2000 ETF | 1.24% | 786.52k | 5.54M |
| Fidelity Small Cap Value Fund | 0.95% | 600k | 4.22M |
| Vanguard Extended Market Index Fund | 0.90% | 566.26k | 3.99M |
| Fidelity Stock Selector Small Cap Fund | 0.87% | 552.5k | 3.89M |
| Fidelity Select Portfolios - Pharmaceuticals | 0.84% | 532.2k | 3.75M |
Why Edgewise Therapeutics Stock Rocked the Market Today
12/24 07:00 pm
The Motley Fool
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
08/17 12:39 pm
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
08/09 12:38 pm
GlobeNewswire Inc.
Read moreEdgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
09/25 11:50 am
Benzinga
Read moreBausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
09/22 05:34 pm
Benzinga
Read moreWhy Edgewise Therapeutics Stock Is Up 50% on Thursday
09/19 12:55 pm
The Motley Fool
Read moreWall Street Analysts Predict a 52.78% Upside in Edgewise Therapeutics, Inc. (EWTX): Here's What You Should Know
02/26 10:55 am
Zacks Investment Research
Read moreWall Street Analysts See a 33.27% Upside in Edgewise Therapeutics, Inc. (EWTX): Can the Stock Really Move This High?
02/09 10:55 am
Zacks Investment Research
Read moreInsiders Buying Edgewise Therapeutics And 2 Other Stocks
01/26 07:34 am
Benzinga
Read moreWall Street Analysts Think Edgewise Therapeutics, Inc. (EWTX) Could Surge 70.76%: Read This Before Placing a Bet
01/24 10:55 am
Zacks Investment Research
Read moreEdgewise (EWTX) Rallies 35% on Issue of New Common Stock
01/22 03:06 pm
Zacks Investment Research
Read moreWorld Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
01/19 11:20 am
Benzinga
Read more3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street
01/16 10:00 am
The Motley Fool
Read moreWall Street Analysts See a 310.1% Upside in Edgewise Therapeutics, Inc. (EWTX): Can the Stock Really Move This High?
10/10 09:55 am
Zacks Investment Research
Read moreNuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
10/06 12:10 pm
Benzinga
Read moreWall Street Analysts Think Edgewise Therapeutics, Inc. (EWTX) Could Surge 327.91%: Read This Before Placing a Bet
09/05 09:55 am
Zacks Investment Research
Read moreWall Street Analysts Believe Edgewise Therapeutics, Inc. (EWTX) Could Rally 224.25%: Here's is How to Trade
08/16 09:55 am
Zacks Investment Research
Read moreAnalyst Ratings for Edgewise Therapeutics
06/27 02:00 pm
Benzinga
Read moreCIRCOR International, Enovix, Edgewise Therapeutics And Other Big Stocks Moving Higher On Tuesday
06/27 10:31 am
Benzinga
Read moreFlexing On Muscular Dystrophy, Analyst Expects Almost 200% Upside For Edgewise Therapeutics
05/01 03:09 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
05/01 11:00 am
Benzinga
Read moreXerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday
04/25 10:27 am
Benzinga
Read moreTop 5 Health Care Stocks That Are Preparing To Pump This Quarter
03/29 07:28 am
Benzinga
Read moreStocks To Watch: Spotlight On Tesla, Nio, Walgreens And Constellation Brands
12/31 11:00 am
Seeking Alpha
Read moreWall Street Analysts Believe Edgewise Therapeutics, Inc. (EWTX) Could Rally 133%: Here's is How to Trade
11/14 10:55 am
Zacks Investment Research
Read moreEdgewise Therapeutics, Inc. (EWTX) Upgraded to Buy: Here's What You Should Know
10/25 12:00 pm
Zacks Investment Research
Read moreWall Street Analysts Believe Edgewise Therapeutics, Inc. (EWTX) Could Rally 157%: Here's is How to Trade
10/25 09:55 am
Zacks Investment Research
Read moreWhy ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
09/16 04:38 am
Benzinga
Read moreEdgewise (EWTX) Up 9.37% on Positive Data From BMD Study
09/13 05:04 pm
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
08/25 10:34 am
Benzinga
Read moreTracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2022 Update
06/06 12:49 am
Seeking Alpha
Read moreThe Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
01/05 09:20 am
Benzinga
Read moreThe Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
01/02 04:30 pm
Benzinga
Read moreStocks To Watch: Eyes On CES, OPEC+ And Electric Vehicle Deliveries
01/01 10:53 am
Seeking Alpha
Read moreTracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2021 Update
09/28 12:25 am
Seeking Alpha
Read moreThe Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
08/27 07:35 am
Benzinga
Read moreThe Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
08/20 07:45 am
Benzinga
Read moreThe Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
08/18 07:37 am
Benzinga
Read moreThe Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
08/17 08:28 am
Benzinga
Read moreThe Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
08/13 07:43 am
Benzinga
Read moreThe Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
08/12 08:09 am
Benzinga
Read moreThe Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
08/11 08:14 am
Benzinga
Read moreThe Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
08/05 08:04 am
Benzinga
Read moreThe Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
07/20 08:19 am
Benzinga
Read moreThe Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
07/02 07:38 am
Benzinga
Read more